Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$549,091,774
+$13,692,887 QoQ
Shares Held
2,162,034
-1.3% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#92
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $1,536,520,507 across 9 Drug Manufacturers - General names. JNJ ranks #1 (35.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,162,034 | $549,091,774 | |
| 2 | LLY |
ELI LILLY & Co
|
396,979 | $476,148,561 | |
| 3 | AZN |
Astrazeneca PLC
|
1,215,636 | $230,508,898 | |
| 4 | ABBV |
AbbVie Inc.
|
775,386 | $195,118,133 | |
| 5 | MRK |
Merck & Co., Inc.
|
520,333 | $66,862,790 | |
| 6 | NVS |
Novartis AG
|
51,084 | $8,005,884 | |
| 7 | PFE |
Pfizer Inc
|
235,637 | $5,674,138 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,979 | $3,052,649 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $549,091,774 | 2,162,034 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $535,398,887 | 2,190,308 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $523,391,864 | 2,529,074 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $189,860,067 | 1,023,946 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $161,602,015 | 1,057,951 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $228,162,174 | 1,375,797 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $183,746,941 | 1,270,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $209,479,404 | 1,292,604 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $190,478,781 | 1,303,221 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $261,605,605 | 1,653,743 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $271,390,921 | 1,731,472 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $251,421,773 | 1,614,265 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $628,029,556 | 3,794,282 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $588,724,410 | 3,798,222 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $598,048,575 | 3,385,500 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $565,839,016 | 3,463,755 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $808,611,303 | 4,555,300 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $596,361,758 | 3,364,903 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $545,682,336 | 3,189,819 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $458,941,333 | 2,841,742 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $471,547,657 | 2,862,375 | Shares | Sole | 2021-08-20 | |
| 2021-03-31 | $443,877,137 | 2,700,804 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $497,748,244 | 3,162,716 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $478,185,289 | 3,211,884 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $446,182,848 | 3,172,743 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $429,904,328 | 3,278,459 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||